# Misoprostol in the Prevention of Postpartum Haemorrhage

> **NCT04044287** · PHASE3 · UNKNOWN · sponsor: **The University of The West Indies** · enrollment: 1496 (estimated)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** 200 micrograms of misoprostol
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT04044287
- **Lead sponsor:** The University of The West Indies
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 1496 (ESTIMATED)
- **Last updated:** 2019-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04044287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04044287, "Misoprostol in the Prevention of Postpartum Haemorrhage". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT04044287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*